Our FREE program includes presentations from science thought leaders and practitioners, events where we explore topical issues in more depth, we¹ll be presenting some of our brightest scientists who will share their exciting work in convergence science. Select one of our seminars below, seats are limited, so please register early to avoid disappointment.
Demystifying Attention Deficit Hyperactivity Disorder (ADHD)
at the Doherty Institute
ADHD is undoubtedly the most controversial disorder of our time. Controversy arises because of the use of psychostimulant medications in its treatment and by a perception that diagnosis rates are escalating exponentially.
Separating fact from fiction is critically important so that the many thousands of individuals affected by ADHD in Australia can gain access to timely diagnosis and treatment and to educational and occupational opportunities.
In this lecture, Professor Luis Rohde, a world-leading expert on ADHD and President of the World Federation of ADHD, will provide a state-of- the-art perspective on ADHD; its diagnosis, epidemiology, biology and treatment.
Luis A Rohde, MD, PHD
Luis A Rohde, MD, PhD is Professor of Child and Adolescent Psychiatry in the Department of Psychiatry at the Federal University of Rio Grande do Sul, Brazil, Director of the Program for Attention-Deficit/Hyperactivity Disorder at the Hospital de Clinicas de Porto Alegre, and Vice-Coordinator of the National Institute of Developmental Psychiatry for Children and Adolescent, Brazil.
He is currently Associate Editor of the Attention Deficit and Hyperactivity Disorder, International Editor of the J Am Acad Child and Adolescent Psychiatry and former Co-Editor of the European Child and Adolescent Psychiatry.
He is President of the World Federation of ADHD, and was former Vice-President of the International Association of Child and Adolescent Psychiatry and Allied Professions. He also was a member of the American Psychiatric Association working group for defining ADHD diagnosis in the DSM-5.
Dr. Rohde’s research interests include ADHD epidemiology, genetics, pharmacogenetics, neuroimaging, and the effects of pharmacological and psychosocial treatments for ADHD. He has published extensively in peer review international and national journals (more than 280 papers), and has been an author or co-author in over 50 book chapters and editorials. He is editor or organizer of 8 books addressing child and adolescent mental health published in Brazil, UK, Germany and the US.
This event is proudly sponsored by the Melbourne Convention Bureau.
Monday 31 July 2017
6.00 pm – 7.00 pm. Refreshments served from 5.15 pm.
The Auditorium, Peter Doherty Institute for Infection and Immunity
792 Elizabeth Street, Melbourne 3000
Buffeted by Global Headwinds: Challenges Facing Biomedical Research
Melbourne Exhibition Centre
Australia’s biomedical research community is the envy of many countries. But we cannot be complacent. Biomedical research in Australia faces a number of challenges. Real funding for research has been falling over time. And a cascade of issues confront the community today. These include, but are not limited to, problems with gender equity, career uncertainty for younger researchers, research translation and reproducibility. Some of our best and brightest see no option but to leave the sector the incentives for those at school to take up the challenge are diminishing, and public trust in the process of translating research into clinical practice is at risk.
A number of the structural and political challenges facing Australian biomedical researchers are local in nature, but many are also shared with our colleagues around the world. Failure to confront these challenges will slow the rate of progress on advances in diagnostics, treatments and therapeutics.
Neglected diseases will probably be starved further of research funding. For millions, the possibility of relief from pain and suffering will recede. As part of National Science Week, the Convergence Science Network is pleased to bring together a distinguished panel for a public conversation about the state of biomedical research in Australia. This is an opportunity to understand the headwinds biomedical research faces and to have a say about how we might respond, to ensure we remain a nation that not only enjoys the benefits of cutting edge health care but contributes to a world where good health is not only the preserve of wealthy nations.
The panel will examine a number of questions including:
Joining us on the panel are:
Who should attend?
This event will be of interest to:
We are grateful for the support of the Club Melbourne Ambassador Program as the venue sponsor.
More about the panelists:
SIR GUSTAV NOSSAL, AC, CBE, FAA, FRS
University of Melbourne
GUSTAV NOSSAL was born in Bad Ischl, Austria, in 1931, and came to Australia with his family in 1939. He studied Medicine at The University of Sydney and, after two years' residency at Royal Prince Alfred Hospital, moved to Melbourne to work at The Walter and Eliza Hall Institute of Medical Research, where he has spent most of his research career in immunology. He has written seven books and over 530 scientific articles in this and related fields. Nossal has served as President of the Australian Academy of Science, President of the International Union of Immunological Societies, Chairman of the Victorian Health Promotion Foundation, Chairman of the committee overseeing the Global Programme for Vaccines and Immunization of the World Health Organization, Chairman of the Strategic Advisory Council of the Bill and Melinda Gates Foundation’s Children’s Vaccine Program and Deputy Chairman of the Council for Aboriginal Reconciliation. He was knighted in 1977, made a Companion of the Order of Australia in 1989 and has received numerous honours from 16 countries. In 2000 he was appointed Australian of the Year. He is currently Professor Emeritus, Department of Pathology, The University of Melbourne and a Principal of Foursight Associates Pty Ltd.
Professor Anne Kelso AO
Professor Anne Kelso AO is the Chief Executive Officer of the National Health and Medical Research Council (NHMRC). Before joining NHMRC in April 2015, Professor Kelso spent many years as a biomedical researcher in immunology alongside other roles, most recently as Director of the WHO Collaborating Centre for Reference and Research on Influenza at the Doherty Institute in Melbourne. She is a member of several Government and international committees, including the Australian Medical Research Advisory Board (advising the Minister for Health on the strategy and priorities for the Medical Research Future Fund), the Board of the Global Alliance for Chronic Diseases (chair-elect) and the Human Frontier Science Program Organization.
Professor John Carroll
Monash Biomedical Discovery Institute
Professor John Carroll, Director, Monash Biomedicine Discovery Institute, Professor of Reproductive Biology, Monash University. Professor Carroll's research focus is on the cell biology of the mammalian oocyte with a view to understanding its role in establishing a healthy pregnancy. His current work is directed toward understanding why eggs become less fertile as maternal age increases.
John has spent most of his academic career at University College London (UCL) where he was Head of Department of Physiology before being appointed Associate Dean and Director of the UCL Division of Biosciences.
Professor Carroll joined Monash University in September 2012 where he is Director of the Monash Biomedicine Discovery Institute and Dean of Biomedical and Psychological Sciences. As Director of the Monash BDI, John is a strong advocate for the essential role of fundamental discovery research in the development of the next generation of medicines and therapeutics and in partnering early with industry to ensure the rapid translation and commercialisation of discoveries. John also chairs the Athena SWAN gender equity team at Monash University.
Prof. Darren Kelly,
Darren is the Company’s CEO and Managing Director bringing over 25 years of management and research expertise in the life sciences and biotech sector. Concurrent to his role with OccuRx, Darren is the Associate Dean (Innovation and Commercialisation, MDHS) at The University of Melbourne, and Director Biomedical Research in the Department of Medicine, St Vincent’s Hospital Melbourne, where his research expertise lies in progressing pre-clinical novel interventions and developing experimental models of cardiovascular disease. He has published over 200 manuscripts in the field of translational research and novel interventions many of which have had a direct impact on human disease. In 2009, Darren was a recipient of the prestigious TJ Neale award for outstanding contribution to nephrology. In 2015 Darren joined the Medical Research Commercialisation Fund as Venture Partner.
Darren has proven history in translational research. He was previously Founder, CEO and Director of Fibrotech Therapeutics, a company that developed orally active anti-fibrotic inhibitors to treat underlying pathological fibrosis in kidney and heart failure, which was ultimately acquired by Shire Plc for a record 75 million USD upfront including milestone payments up to 600 million USD.
Darren has a PhD in Translational Medicine from the University of Melbourne. He is a current member of the Australian Institute of Company Directors, AusBiotech, BioMelbourne Network and a Fellow of the American Society of Nephrology.
Dr Sarah Meachem
Hudson Institute of Medical Research
Dr Sarah Meachem is an academic researcher and a health and medical research advocate. She completed her PhD at Monash University in 1999 where she studied hormonal control of testis function, at the Hudson Institute of Medical Research and the author of more than 80 publications. She has engaged in numerous leadership and advocacy roles in the broader Health sector in Australia. Sarah is a Director of the Australian Institute of Policy and Science, a Manager for the co-badged PhD International Research Training Program between Germany and Australia (Monash & Giessen Universities) and was a Director and Past President twice of the peak advocacy for health and medical research, The Australian Society for Medical Research, the associate Director of the Children Cancer Institute Australia (NSW), and a Senior Leader at the National Health and Medical Research Council Australia (ACT). She was the fortunate recipient of the Victorian Tall Poppy Awards for research and communication excellence (2007) and ambassador of the program (Australian Institute of Policy and Science) and was awarded the Australian Leadership award for her vision for the nation’s health sector in 2011. She has 5 years formal communication training in 'leadership, power and performance' and is dedicated to building a fully integrated health care system and a sustainable career structure for the health and medical research workforce.
Dr Rachel Nowak
University of Melbourne
Dr Nowak is recently appointed as Associate Director, Strategic Communications in the Research, Innovation and Commercialisation portfolio at the University of Melbourne.
Previously, Rachel was founder-director of The Brain Dialogue, a prototype engagement program fostering two-way dialogue between the public and researchers about brain research and where it should take us. The Brain Dialogue is an initiative of the Australian Research Council Centre of Excellence for Integrative Brain Function,
Rachel was also principle at Rachel Nowak and Associates, a consultancy that developed new and existing enterprises to share scientific knowledge for innovation, Responsible Research and Innovation (RRI), improving public health and enriching lives, and to link industry and academia. She has a PhD and two post-docs in circadian physiology, and an MA from the Writing Seminars at Johns Hopkins University in Baltimore.
Rachel has worked for several US science and biotech publications, including Science, as senior writer covering biomedicine. She has taught science writing at Johns Hopkins University, and worked at New Scientist, firstly as Washington Bureau Chief, and then as Australasian Editor.
She is a member of the Gene Technology Ethics and Community Consultative Committee of the Office of the Gene Technology Regulator, Department of Health; a non-Executive Director of COSMOS Media Pty Ltd; and a member of the Advisory Board, ARC Centre of Excellence for All-Sky Astrophysics.
This is a free event but registration is essential.
Monday, 14 August 2017
6.00 pm – 7.30 pm.
Clarendon Auditorium, Level 2, Melbourne Exhibition Centre,
2 Clarendon Street, South Wharf (Opposite Crown Casino)
About the Convergence Forum
The Convergence Science Network will announce a series of events in early 2015. Our program will include presentations from science thought leaders and practitioners, events where we explore topical issues in more depth and we¹ll be presenting some of our brightest scientists who will share their exciting work in convergence science.
Graeme Clark Oration
The Graeme Clark Oration is delivered by global leaders in science in honour of Prof. Graeme Clark’s pioneering work in developing the bionic ear in Melbourne in the 1970’s. It is recognised as Australia’s most prestigious free public science event and is attended by secondary school students.
Convergence Science Symposium
The Convergence Science Network is an initiative that promotes an understanding of convergence science to the community, why it is important and how it is helping researchers and businesses realise their visions in delivering improved health and well-being.
Join our community
The Convergence Science Network is excited about its networking activities and is inviting organisations to join this unique science communication and engagement initiative.
Contact us to find out the exclusive benefits available to Network sponsors. We also offer an Individual Membership package of benefits.
We Engage with the community to share developments in convergence science and how these advances impact medicine and health care.
We Inspire the research community, start-ups, existing businesses, government agencies and schools to take advantage of the opportunities offered by convergence science.
We Create the environment and opportunities for new ideas, knowledge and resources across different science disciplines to come together to improve health.